De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
| Sneeuwvlok Score | |
|---|---|
| Waardering | 2/6 |
| Toekomstige groei | 2/6 |
| Prestaties in het verleden | 0/6 |
| Financiële gezondheid | 4/6 |
| Dividenden | 0/6 |
Beloningen
Risicoanalyse
+ 1 meer risico
Cue Health Inc. Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | US$0.091 |
| 52 Week Hoogtepunt | US$0.78 |
| 52 Week Laag | US$0.078 |
| Bèta | 1.3 |
| 11 maand verandering | -35.74% |
| 3 maanden verandering | -64.64% |
| 1 Jaar Verandering | -87.13% |
| 33 jaar verandering | n/a |
| 5 jaar verandering | n/a |
| Verandering sinds IPO | -99.55% |
Recent nieuws en updates
Recent updates
Take Care Before Jumping Onto Cue Health Inc. (NASDAQ:HLTH) Even Though It's 26% Cheaper
May 10
Investors Don't See Light At End Of Cue Health Inc.'s (NASDAQ:HLTH) Tunnel And Push Stock Down 26%
Mar 22Cue Health Inc.'s (NASDAQ:HLTH) Price Is Right But Growth Is Lacking After Shares Rocket 31%
Jan 28We're A Little Worried About Cue Health's (NASDAQ:HLTH) Cash Burn Rate
Jan 06Investors Don't See Light At End Of Cue Health Inc.'s (NASDAQ:HLTH) Tunnel And Push Stock Down 28%
Nov 10These Analysts Think Cue Health Inc.'s (NASDAQ:HLTH) Sales Are Under Threat
Aug 14Can Cue Health (NASDAQ:HLTH) Afford To Invest In Growth?
Jul 12Revenue Downgrade: Here's What Analysts Forecast For Cue Health Inc. (NASDAQ:HLTH)
May 15Cue Health Inc. (NASDAQ:HLTH) Analysts Just Slashed This Year's Revenue Estimates By 56%
Mar 21We Think Cue Health (NASDAQ:HLTH) Needs To Drive Business Growth Carefully
Mar 12Cue Health Inc.'s (NASDAQ:HLTH) Intrinsic Value Is Potentially 44% Above Its Share Price
Feb 13Cue Health Inc. (NASDAQ:HLTH) Analysts Just Trimmed Their Revenue Forecasts By 24%
Nov 18Here's Why We're Not Too Worried About Cue Health's (NASDAQ:HLTH) Cash Burn Situation
Oct 30Cue Health applies for FDA emergency use nod for its flu & COVID-19 molecular test
Oct 04Cue Health appoints chief medical oficer
Sep 08Rendement voor aandeelhouders
| HLTH | US Medical Equipment | US Markt | |
|---|---|---|---|
| 7D | -23.2% | -0.6% | -0.4% |
| 1Y | -87.1% | 22.6% | 34.1% |
Rendement versus industrie: HLTH presteerde slechter dan de US Medical Equipment -sector, die het afgelopen jaar een rendement van 22.3 % opleverde.
Rendement versus markt: HLTH presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 33.4 % opleverde.
Prijsvolatiliteit
| HLTH volatility | |
|---|---|
| HLTH Average Weekly Movement | 17.0% |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 3.1% |
Stabiele aandelenkoers: De aandelenkoers van HLTH is de afgelopen 3 maanden volatiel geweest.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 17% ) van HLTH is het afgelopen jaar stabiel geweest, maar is nog steeds hoger dan 75% van de aandelen US.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 2010 | 726 | Clint Sever | www.cuehealth.com |
Cue Health Inc. Samenvatting
| HLTH fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | US$14.72m |
| Inkomsten(TTM) | -US$373.46m |
| Inkomsten(TTM) | US$70.94m |
0.2x
P/S-verhouding0.0x
Koers/WinstverhoudingIs HLTH overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| HLTH resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$70.94m |
| Kosten van inkomsten | US$265.71m |
| Brutowinst | -US$194.77m |
| Overige uitgaven | US$178.69m |
| Inkomsten | -US$373.46m |
Laatst gerapporteerde inkomsten
Dec 31, 2023
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | -2.35 |
| Brutomarge | -274.58% |
| Nettowinstmarge | -526.48% |
| Schuld/Eigen Vermogen Verhouding | 0% |
Hoe presteerde HLTH op de lange termijn?
Bekijk historische prestaties en vergelijking